Poseida Therapeutics Announces Proposed Public Offering of Common Stock

SAN DIEGO, Aug. 4, 2022 /PRNewswire/ — Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform technologies to create cell and gene therapeutics with the capacity to cure, today announced that it has…

Click here to view original post